1
|
Cogliati M. Global warming impact on the expansion of fundamental niche of Cryptococcus gattii VGI in Europe. ENVIRONMENTAL MICROBIOLOGY REPORTS 2021; 13:375-383. [PMID: 33945219 PMCID: PMC8251527 DOI: 10.1111/1758-2229.12945] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/11/2020] [Revised: 03/29/2021] [Accepted: 04/01/2021] [Indexed: 06/12/2023]
Abstract
In the present study, we analysed how geographical distribution of the fungal pathogen Cryptococcus gattii VGI in Europe and Mediterranean area has evolved in the last four decades based on the climatic changes, and we tried to predict the scenario for the next decade. Niche modelling by Maxent analysis showed that recent climate changes have significantly affected the distribution of the fungus revealing a gradual expansion of the fundamental niche from 1980 to 2009 followed by an impressive increase in the last decade (2010-2019) during which the environmental surface suitable for the fungal survival was more than doubled. In the next decade, our model predicted an increase in the area of distribution of C. gattii VGI from the coasts of the Mediterranean basin towards the more internal sub-continental areas. On the basis of these predictions, an increase of cases of cryptococcosis due to C. gattii VGI is expected in the next decade and a constant monitoring of the epidemiology of this fungal pathogen represents a crucial strategy to detect the onset of future outbreaks.
Collapse
Affiliation(s)
- Massimo Cogliati
- Lab. Medical Mycology, Dip. Scienze Biomediche per la Salute, Università degli Studi di MilanoMilanItaly
| |
Collapse
|
2
|
Bellet V, Kassi FK, Krasteva D, Roger F, Drakulovski P, Mossou C, Kouakou GA, Doumbia A, Delaporte E, Menan H, Bertout S. First report of cryptococcosis due to Cryptococcus gattii sensu stricto VGI in an Ivorian HIV negative patient. J Mycol Med 2021; 31:101113. [PMID: 33540367 DOI: 10.1016/j.mycmed.2021.101113] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2020] [Revised: 01/12/2021] [Accepted: 01/13/2021] [Indexed: 02/06/2023]
Abstract
INTRODUCTION Cryptococcus gattii species complex is endemic to tropical and subtropical regions and is described as a causative agent of cryptococcosis in immunocompetent individuals. CASE PRESENTATION We describe the first case of cryptococcosis in a HIV-negative patient from Ivory Coast infected by Cryptococcus gattii sensu stricto VGI. Isolates were recovered from cerebrospinal fluid (CSF) prior to systemic antifungal treatment up to 42 days after detection of the presence of yeasts in the CSF. Eighteen isolates were recovered, genetic diversity and antifungal susceptibility analyses were performed. All the isolates belonged to the Cryptococcus gattii sensu stricto (B;VGI) and were identified as a new sequence type (ST) 553 by Multilocus Sequence Typing (MLST) analyses. Susceptibility testing showed that all the strains had a wild-type phenotype for fluconazole, amphotericin B and flucytosine. Treatment with fluconazole (1200mg/day) was initiated with success. CONCLUSION This is the first case report of the presence of C. gattii sensu stricto VGI in a HIV-negative ivorian patient and the second report of the presence of species from the C. gattii complex species in this country.
Collapse
Affiliation(s)
- V Bellet
- UMI 233 IRD-UM Inserm U1175 TransVIHMI, Infections Fongique et Parasitaire Laboratoire de Parasitologie et de Mycologie Médicale, UFR Pharmacie, Montpellier cedex 5, France.
| | - F K Kassi
- Laboratoire de Parasitologie et de Mycologie - CeDReS (Centre de Diagnostic et de Recherche sur le SIDA et les Autres Maladies Infectieuses), UFR Pharmacie, CHU de Treichville, Université Félix Houphouët Boigny, Abidjan, Ivory Coast
| | - D Krasteva
- UMI 233 IRD-UM Inserm U1175 TransVIHMI, Infections Fongique et Parasitaire Laboratoire de Parasitologie et de Mycologie Médicale, UFR Pharmacie, Montpellier cedex 5, France
| | - F Roger
- UMI 233 IRD-UM Inserm U1175 TransVIHMI, Infections Fongique et Parasitaire Laboratoire de Parasitologie et de Mycologie Médicale, UFR Pharmacie, Montpellier cedex 5, France
| | - P Drakulovski
- UMI 233 IRD-UM Inserm U1175 TransVIHMI, Infections Fongique et Parasitaire Laboratoire de Parasitologie et de Mycologie Médicale, UFR Pharmacie, Montpellier cedex 5, France
| | - C Mossou
- Centre de Diagnostic et de Recherche sur le SIDA et les Autres Maladies Infectieuses, CHU de Treichville, Abidjan, Ivory Coast
| | - G A Kouakou
- Centre de Diagnostic et de Recherche sur le SIDA et les Autres Maladies Infectieuses, CHU de Treichville, Abidjan, Ivory Coast
| | - A Doumbia
- Centre de Diagnostic et de Recherche sur le SIDA et les Autres Maladies Infectieuses, CHU de Treichville, Abidjan, Ivory Coast
| | - E Delaporte
- UMI 233 IRD-UM Inserm U1175 TransVIHMI, Service des Maladies Infectieuses et Tropicales, CHU Gui de Chauliac, Montpellier, France
| | - H Menan
- Laboratoire de Parasitologie et de Mycologie - CeDReS (Centre de Diagnostic et de Recherche sur le SIDA et les Autres Maladies Infectieuses), UFR Pharmacie, CHU de Treichville, Université Félix Houphouët Boigny, Abidjan, Ivory Coast
| | - S Bertout
- UMI 233 IRD-UM Inserm U1175 TransVIHMI, Infections Fongique et Parasitaire Laboratoire de Parasitologie et de Mycologie Médicale, UFR Pharmacie, Montpellier cedex 5, France
| |
Collapse
|